By Matthew Vorsanger, MD
Peer Reviewed
As we spend time with family and friends on this beautiful Memorial Day weekend, we also ponder the senseless and tragic killings recently committed in Isla Vista, …
Clinical Correlations
The NYU Langone Health Online Journal of Medicine
Gay Men, Barebacking and the New Little Blue Pill: The awkward interface of medicine and gay sex.
May 23, 2014
By Richard E. Greene, MD
Peer Reviewed
In July of 2012, the FDA approved the use of Tenofovir-Emtricitabine (Truvada, a single blue pill) daily as Pre-Exposure Prophylaxis (PrEP) in …
From The Archives: Metabolic Syndrome: Fact or Myth?
May 22, 2014Please enjoy this post from the archives dated September 30, 2011
By Vicky Jones, MD
A 40-year-old female presented to her primary care provider with a chief complaint of weight gain over the past year. She wants to be fully evaluated for any …
Help Versus Hope: Acetylcholinesterase Inhibitors in Alzheimer’s Disease
May 21, 2014
By Jonathan Gursky
Peer Reviewed
Approximately 5.2 million Americans are currently living with Alzheimer’s disease (AD) [1], with this number expected to triple by the year 2050 [2]. Alzheimer’s disease is …
Primecuts – This Week In The Journals
May 20, 2014
By Mark Adelman, MD
Peer Reviewed
The Centers for Disease Control and Prevention CDC confirmed on May 12 that a second case of Middle East Respiratory …
Timekeeping
May 16, 2014
By Nancy Hernandez
I did not know you until that time,
We scurried into your room
And found you pulseless, breathless, lifeless.
I was asked to keep
Time.
Fumbling for paper, I resorted to …
HotSpots: The Evolution of Medicine
May 15, 2014
Welcome to HotSpots. In this series, we highlight unique websites of interest to the medical profession. Feel free to make suggestions for sites that should be featured in this series by clicking the comment field or sending us an email.
Matthew …
New Cholesterol Guidelines: How Safe Are High-Potency Statins?
May 14, 2014
By Molly Anderson
Peer Reviewed
Managing hyperlipidemia is a mainstay of cardiovascular risk reduction. The 2013 ACC/AHA guidelines no longer target specific low-density lipoprotein (LDL)-cholesterol levels, but recommend lipid-lowering therapies of varying …